Clinical Trial
Accepted on 09 Feb 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: Findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study
in Inflammation Pharmacology
Clinical Trial
Accepted on 09 Feb 2026
in Inflammation Pharmacology
Original Research
Accepted on 09 Feb 2026
in Injury Prevention and Rehabilitation
Original Research
Accepted on 09 Feb 2026
in Respiratory Pharmacology
Original Research
Accepted on 09 Feb 2026
in Health Psychology
Original Research
Accepted on 09 Feb 2026
in Infectious Agents and Disease
Original Research
Accepted on 09 Feb 2026
in Clinical Nutrition
Original Research
Accepted on 09 Feb 2026
in Microbial Symbioses
Original Research
Accepted on 09 Feb 2026
in Health Psychology
Systematic Review
Accepted on 09 Feb 2026
in Aging and Public Health
Original Research
Accepted on 09 Feb 2026
in Obstetrics and Gynecology
Original Research
Accepted on 09 Feb 2026
in Health Psychology
Original Research
Accepted on 09 Feb 2026
in Pediatric Cardiology
Correction
Accepted on 09 Feb 2026
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 09 Feb 2026
in Neurological Biomarkers
Original Research
Accepted on 09 Feb 2026
in Molecular Innate Immunity
Mini Review
Accepted on 09 Feb 2026
in Molecular Innate Immunity